European Medical Solutions (ALEMS.BR)

EUR 0.02

(-4.17%)

Gross Profit Summary of European Medical Solutions

European Medical Solutions's latest annual gross profit in 2023 was 13.51 Million EUR , up 9.52% from previous year.
European Medical Solutions's latest quarterly gross profit in 2023 FY was 15.08 Million EUR , up 9.52% from previous quarter.
European Medical Solutions reported a annual gross profit of 13.77 Million EUR in annual gross profit 2022, down -0.2% from previous year.
European Medical Solutions reported a annual gross profit of 13.8 Million EUR in annual gross profit 2021, up 3745.45% from previous year.
European Medical Solutions reported a quarterly gross profit of 15.08 Million EUR for 2023 FY, up 9.52% from previous quarter.
European Medical Solutions reported a quarterly gross profit of 6.36 Million EUR for 2023 Q4, down -27.13% from previous quarter.

Annual Gross Profit Chart of European Medical Solutions (2023 - 2013)

Historical Annual Gross Profit of European Medical Solutions (2023 - 2013)

Year	Gross Profit	Gross Profit Growth
2023	13.51 Million EUR	9.52%
2022	13.77 Million EUR	-0.2%
2021	13.8 Million EUR	3745.45%
2020	358.94 Thousand EUR	-66.29%
2019	1.06 Million EUR	86.57%
2018	570.75 Thousand EUR	-5.5%
2017	604 Thousand EUR	-64.12%
2016	1.68 Million EUR	168215.7%
2015	1000.00 EUR	-80.0%
2014	5000.00 EUR	-50.0%
2013	10 Thousand EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2023 Q2	8.72 Million EUR	43.91%
2023 FY	15.08 Million EUR	9.52%
2023 Q4	6.36 Million EUR	-27.13%
2022 Q4	6.06 Million EUR	-21.35%
2022 FY	13.77 Million EUR	-0.2%
2022 Q2	7.71 Million EUR	1857972.29%
2021 FY	13.8 Million EUR	3745.45%
2021 Q4	415.00 EUR	0.0%
2021 Q2	- EUR	-100.0%
2020 Q2	16 Thousand EUR	-92.23%
2020 FY	358.94 Thousand EUR	-66.29%
2020 Q4	342.94 Thousand EUR	2043.4%
2019 Q4	205.84 Thousand EUR	-76.04%
2019 FY	1.06 Million EUR	86.57%
2019 Q2	859 Thousand EUR	362.45%
2018 Q4	185.75 Thousand EUR	-51.75%
2018 FY	570.75 Thousand EUR	-5.5%
2018 Q2	385 Thousand EUR	26.64%
2017 Q2	300 Thousand EUR	-78.33%
2017 Q4	304 Thousand EUR	1.33%
2017 FY	604 Thousand EUR	-64.12%
2016 Q2	298 Thousand EUR	15000.0%
2016 FY	1.68 Million EUR	168215.7%
2016 Q4	1.38 Million EUR	364.61%
2015 Q2	3000.00 EUR	0.0%
2015 Q4	-2000.00 EUR	-166.67%
2015 FY	1000.00 EUR	-80.0%
2014 FY	5000.00 EUR	-50.0%
2013 FY	10 Thousand EUR	0.0%

Peer Gross Profit Comparison of European Medical Solutions

Name	Gross Profit	Gross Profit Difference
Nicox S.A.	-11.5 Million EUR	217.456%
FERMENTALG	535 Thousand EUR	-2425.421%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	-918.929%